CGH
HUM icon

Crossmark Global Holdings’s Humana HUM Stock Holding History

Crossmark Global Holdings’s Portfolio HUM Stock Details HUM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.12M Sell
10,379
-428
-4% -$122K 0.05% 294
2026
Q1 		$1.87M Buy
10,807
+432
+4% +$88.5K 0.03% 451
2025
Q4 		$2.66M Buy
10,375
+2,320
+29% +$608K 0.04% 370
2025
Q3 		$2.1M Sell
8,055
-13,829
-63% -$3.64M 0.03% 434
2025
Q2 		$5.35M Buy
21,884
+12,520
+134% +$3.12M 0.09% 236
2025
Q1 		$2.48M Buy
9,364
+296
+3% +$80.1K 0.04% 368
2024
Q4 		$2.3M Buy
9,068
+915
+11% +$245K 0.04% 366
2024
Q3 		$2.58M Buy
8,153
+388
+5% +$138K 0.05% 354
2024
Q2 		$2.9M Sell
7,765
-14,356
-65% -$4.85M 0.06% 320
2024
Q1 		$7.67M Buy
22,121
+1,029
+5% +$390K 0.15% 165
2023
Q4 		$9.66M Buy
21,092
+1,747
+9% +$861K 0.2% 135
2023
Q3 		$9.68M Sell
19,345
-1,799
-9% -$845K 0.22% 121
2023
Q2 		$9.59M Buy
21,144
+2,273
+12% +$1.14M 0.21% 129
2023
Q1 		$9.16M Buy
18,871
+5,590
+42% +$2.76M 0.22% 125
2022
Q4 		$6.8M Buy
13,281
+2,477
+23% +$1.3M 0.17% 154
2022
Q3 		$5.24M Buy
10,804
+840
+8% +$409K 0.15% 171
2022
Q2 		$4.66M Sell
9,964
-20
-0.2% -$8.9K 0.12% 201
2022
Q1 		$4.34M Sell
9,984
-2,469
-20% -$1.03M 0.1% 225
2021
Q4 		$5.78M Buy
12,453
+2,103
+20% +$931K 0.13% 182
2021
Q3 		$4.03M Sell
10,350
-275
-3% -$117K 0.09% 226
2021
Q2 		$4.7M Buy
10,625
+1,295
+14% +$566K 0.11% 195
2021
Q1 		$3.91M Sell
9,330
-680
-7% -$271K 0.1% 223
2020
Q4 		$4.11M Sell
10,010
-206
-2% -$85.6K 0.1% 211
2020
Q3 		$4.23M Buy
10,216
+931
+10% +$374K 0.12% 188
2020
Q2 		$3.6M Sell
9,285
-598
-6% -$224K 0.11% 216
2020
Q1 		$3.1M Sell
9,883
-82
-0.8% -$27.7K 0.11% 208
2019
Q4 		$3.65M Sell
9,965
-3,820
-28% -$1.21M 0.1% 233
2019
Q3 		$3.52M Sell
13,785
-1,556
-10% -$436K 0.1% 231
2019
Q2 		$4.07M Buy
15,341
+823
+6% +$209K 0.11% 214
2019
Q1 		$3.86M Buy
14,518
+267
+2% +$76.9K 0.11% 219
2018
Q4 		$4.08M Buy
14,251
+946
+7% +$300K 0.13% 204
2018
Q3 		$4.5M Sell
13,305
-948
-7% -$308K 0.11% 214
2018
Q2 		$4.24M Sell
14,253
-299
-2% -$87.6K 0.11% 215
2018
Q1 		$3.91M Sell
14,552
-1,611
-10% -$436K 0.1% 245
2017
Q4 		$4.01M Sell
16,163
-1,127
-7% -$278K 0.1% 257
2017
Q3 		$4.21M Buy
+17,290
New +$4.24M 0.11% 228
2016
Q3 		$4.21M Buy
+17,290
New +$3M 0.11% 228

Other funds holding HUM

HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
WC
Westwind Capital Las Cruces, New Mexico $422M AUM 17.03% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM

Crossmark Global Holdings's HUM Position: Q2 2026 in Review

Crossmark Global Holdings reduced its Humana (HUM) stake by 4% in Q2 2026, selling an estimated $122K and leaving 10,379 shares worth $4.12M. The position accounts for 0.05% of the portfolio, ranked #294.

Crossmark Global Holdings first reported a position in HUM in Q3 2016 and has held it in 37 quarters since. The position peaked at $9.68M in Q3 2023. 178 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Crossmark Global Holdings held 10,379 shares of Humana worth $4.12M as of Q2 2026.
  • Crossmark Global Holdings sold 428 Humana shares in Q2 2026, an estimated $122K.
  • Humana made up 0.05% of Crossmark Global Holdings's portfolio in Q2 2026, its #294 holding.
  • Crossmark Global Holdings first reported a position in Humana in Q3 2016 and has held it in 37 quarters since.
  • Crossmark Global Holdings's Humana position peaked at $9.68M in Q3 2023.
  • 178 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.